Elisha Singer, M.D.
Dermatologist
Nattkemper LA, Martinez-Escala ME, Gelman AB,
Singer EM
, Rook AH, Guitart J, Yosipovitch G. Cutaneous T-cell Lymphoma and Pruritus: The Expression of IL-31 and its Receptors in the Skin. Acta Derm Venereol. 2016 Nov 2; 96 (7):894-898
View PubMed
Cedeno-Laurent F,
Singer EM
, Wysocka M, Benoit BM, Vittorio CC, Kim EJ, Yosipovitch G, Rook AH. Improved pruritus correlates with lower levels of IL-31 in CTCL patients under different therapeutic modalities. Clin Immunol. 2015 May; 158 (1):1-7 Epub 2015 Mar 08
View PubMed
Wysocka M, Kossenkov AV, Benoit BM, Troxel AB,
Singer E
, Schaffer A, Kim B, Dentchev T, Nagata S, Ise T, Showe LC, Rook AH. CD164 and FCRL3 are highly expressed on CD4+CD26- T cells in Sezary syndrome patients. J Invest Dermatol. 2014 Jan; 134 (1):229-236 Epub 2013 June 21
View PubMed
Singer EM
, Shin DB, Nattkemper LA, Benoit BM, Klein RS, Didigu CA, Loren AW, Dentchev T, Wysocka M, Yosipovitch G, Rook AH. IL-31 is produced by the malignant T-cell population in cutaneous T-Cell lymphoma and correlates with CTCL pruritus. J Invest Dermatol 2013 Dec; 133 (12):2783-2785 Epub 2013 May 22
View PubMed
.
Mayo Clinic Footer